Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction: SGK Kinase Activity in Multiple Myeloma Cells Protects against ER Stress Apoptosis via a SEK-Dependent Mechanism.

Molecular cancer research : MCR·2026
Same author

Efficacy of an Fc-silent antibody targeting the apical domain of human transferrin receptor 1 in transgenic mouse models of Junín virus infection.

Antiviral research·2026
Same author

A Transgenic Syrian Hamster Model for New World Hemorrhagic Fever Mammarenavirus Infection.

Research square·2026
Same author

A proimmunotoxin nanodrug targeting AIDS-associated non-Hodgkin lymphoma.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Characterization of IgE cross-reactivity and allergenicity of peanut allergens.

ImmunoHorizons·2025
Same author

hu128.1, a humanized antibody targeting transferrin receptor 1, blocks erythroleukemia growth in xenograft mouse models.

Haematologica·2024

Related Experiment Video

Updated: May 9, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Iron in multiple myeloma.

Kristina VanderWall1, Tracy R Daniels-Wells, Manuel Penichet

  • 1Division of Hematology-Oncology, Department of Medicine, UCLA David Geffen School of Medicine.

Critical Reviews in Oncogenesis
|July 25, 2013
PubMed
Summary
This summary is machine-generated.

Multiple myeloma patients experience anemia due to impaired iron use. Cytokines increase hepcidin, disrupting iron metabolism and causing anemia. Targeting iron metabolism offers a potential therapeutic strategy.

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

Related Experiment Videos

Last Updated: May 9, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

Area of Science:

  • Hematology
  • Oncology
  • Biochemistry

Background:

  • Multiple myeloma is a B-cell malignancy with significant anemia.
  • Anemia in multiple myeloma stems from impaired iron utilization.
  • Hepcidin, regulated by cytokines, is implicated in this iron dysregulation.

Purpose of the Study:

  • To review the role of iron metabolism in multiple myeloma.
  • To describe the biochemical abnormalities causing anemia in multiple myeloma.
  • To discuss initial therapeutic strategies targeting iron metabolism.

Main Methods:

  • Review of recent studies on iron metabolism in multiple myeloma.
  • Analysis of cytokine-induced hepcidin upregulation.
  • Examination of therapeutic approaches targeting iron influx in myeloma cells.

Main Results:

  • Dysregulated iron metabolism and anemia are linked to hepcidin upregulation.
  • Myeloma cells exhibit increased iron dependency.
  • Targeting iron metabolism is an emerging therapeutic avenue.

Conclusions:

  • Iron metabolism is critical in multiple myeloma pathogenesis and anemia.
  • Hepcidin plays a key role in mediating anemia in this malignancy.
  • Therapeutic targeting of iron metabolism shows promise for multiple myeloma treatment.